SCHEMBL7947314

SCHEMBL7947314

FC(F)(F)Sc1ccc(OC2CCN(c3ccncc3)C2)cc1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACACB O00763 18/20 0.46
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
PDE10A Q9Y233 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958655 0.85 LIPG (0.50) ACACB
SCHEMBL7956496 0.84 PDE3B (0.51) ACACBPDE3BPDE3APDE10A
SCHEMBL7961730 0.84 ACACB (0.51) ACACBPDE3BPDE3APDE10A
SCHEMBL7956152 0.80 ACACB (0.52) ACACBPDE3BPDE3APDE10A
SCHEMBL7956662 0.79 ACACB (0.55) ACACBPDE3BPDE3APDE10A
SCHEMBL7956861 0.79 ACACB (0.51) ACACBPDE3BPDE3APDE10A
SCHEMBL15441838 0.78 ESR1 (0.42) ACACB
SCHEMBL7955313 0.77 ACACB (0.49) ACACBPDE3BPDE3APDE10A
SCHEMBL7956683 0.76 HRH3 (0.58) ACACBPDE3BPDE3APDE10A
SCHEMBL7961508 0.76 ACACB (0.51) ACACBPDE3BPDE3APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed